For R&D use onlynot for drug household or other uses.

Hexamethonium is a non-depolarising ganglionic blocker a nicotinic nACh (NN) receptor antagonist.Target nAChRHexamethonium is a non-depolarising ganglionic blocker a nicotinic nACh receptor antagonist that acts in autonomic ganglia by binding mostly in or on the NN receptor and not the acetylcholine binding site itself. It does not have any effect on the muscarinic acetylcholine receptors (mAChR) located on target organs of the parasympathetic nervous system but acts as antagonist at the nicotinic acetylcholine receptors located in sympathetic and parasympathetic ganglia (NN).